Pulsed-field gel electrophoresis analysis of bordetella pertussis isolates circulating in europe from 1998 to 2009

Journal of Clinical Microbiology

Volumn 51, Issue 2, 2013, Pages 422-428

  Advani, Abdolreza ^a   Hallander, Hans O ^a   Dalby, Tine ^b   Krogfelt, Karen Angeliki ^b   Guiso, Nicole ^c   Njamkepo, Elisabeth ^c   Von Könnig, Carl Heinz Wirsing ^d   Riffelmann, Marion ^d   Mooi, Frits R ^e   Sandven, Per ^f   Lutyńska, Anna ^g   Fry, Norman K ^h   Mertsola, Jussi ⁱ   He, Qiushui ^j  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c INSTITUT PASTEUR   (France)

^d Klinikum Krefeld   (Germany)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^g NATIONAL MEDICINES INSTITUTE   (Poland)

^h PUBLIC HEALTH ENGLAND   (United Kingdom)

ⁱ UNIVERSITY OF TURKU   (Finland)

^j NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; POLIOMYELITIS VACCINE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CHILD; DENMARK; FINLAND; FRANCE; GERMANY; HUMAN; INFANT; NETHERLANDS; NONHUMAN; NORWAY; PRESCHOOL CHILD; PRIORITY JOURNAL; PTXP3 GENE; PULSED FIELD GEL ELECTROPHORESIS; SCHOOL CHILD; SWEDEN; UNITED KINGDOM; VACCINATION;

BORDETELLA PERTUSSIS; CHILD, PRESCHOOL; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; EUROPE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT; INFANT, NEWBORN; PERTUSSIS VACCINE; PHYLOGENY; WHOOPING COUGH;

EID: 84873048721     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02036-12     Document Type: Article

References (38)

1. Celentano L, Massari M, Paramatti D, Salmaso S, Tozzi A. 2005. Resurgence of pertussis in Europe. Pediatr. Infect. Dis. J. 24:761-765.
2. Centers for Disease Control and Prevention. 2010 Pertussis: surveillance and reporting. http://www.cdc.gov/pertussis/surv-reporting.html#case-definition. Accessed 16 May 2012.
3. Gzyl A, Augustynowicz E, Rabczenko D, Gniadek G, Slusarczyk J. 2004. Pertussis in Poland. Int. J. Epidemiol. 33:358 -365.
4. Halperin SA. 2007. The control of pertussis-2007 and beyond. N. Engl. J. Med. 356:110 -113.
5. Lavine JS, Bjørnstad ON, de Blasio BF, Storsaeter J. 2012. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine 20:544 -551.
6. Mooi FR, van Loo IH, King AJ. 2001. Adaptation of bordetella pertussis vaccination: a cause for its reemergence? Emerg. Infect. Dis. 7:526 -528.
7. Roehr B. 2010. Whooping cough outbreak hits several US states. BMJ 341:c4627.
8. Spokes PJ, Quinn HE, McAnulty JM. 2010. Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations. N.S.W. Public Health Bull. 21:167-173.
9. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, Grimprel E, Greenberg D, Halperin S, Liese J, Muñoz-Rivas F, Teyssou R, Guiso N, Van Rie A, Infant Pertussis Study Group. 2007. Transmission of bordetella pertussis to young infants. Pediatr. Infect. Dis. J. 26:293-299.
10. Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P. 2011. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect. Dis. 11:557-570.
11. Euvac.net. 2011. http://www.euvac.net/graphics/euvac/vaccination/ pertussis.html Accesses 30 July 2012.
12. He Q, Mertsola J. 2008. Factors contributing to pertussis resurgence. Future Microbiol. 3:329 -339.
13. Elomaa A, Advani A, Donnelly D, Antila M, Mertsola J, Hallander H, He Q. 2005. Strain variation among bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. J. Clin. Microbiol. 43:3681-3687.
14. Fry NK, Neal S, Harrison TG, Miller E, Matthews R, George RC. 2001. Genotypic variation in the bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect. Immun. 69:5520 -5528.
15. Gzyl A, Augustynowicz E, van Loo I, Slusarczyk J. 2001. Temporal nucleotide changes in pertactin and pertussis toxin genes in bordetella pertussis strains isolated from clinical cases in Poland. Vaccine 20:299- 303.
16. Hallander HO, Advani A, Donnelly D, Gustafsson L, Carlsson RM. 2005. Shifts of bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J. Clin. Microbiol. 43:2856 -2865.
17. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. 1998. Polymorphism in the bordetella pertussis virulence factors P. 69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66:670- 675.
18. Petersen RF, Dalby T, Dragsted DM, Mooi F, Lanbertsen L. 2012. Temporal trends in bordetella pertussis populations, Denmark, 1949- 2010. Emerg. Infect. Dis. 18:767-774.
19. Weber C, Boursaux-Eude C, Coralie G, Caro V, Guiso N. 2001. Polymorphism of bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J. Clin. Microbiol. 39:4396-4403.
20. Mooi FR, van Loo IHM, van Gent M, He Q, Heuvelman CJ, Bart MJ, de Greeff SC, Diavatopoulos DA, Teunis PF, Nagelkerke NJ, Mertsola J. 2009. bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg. Infect. Dis. 15:1206 -1213.
21. Advani A, Gustafsson L, Ahren C, Mooi FR, Hallander HO. 2011. Appearance of Fim3 and ptxP3-bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine 29:3438 -3442.
22. Hegerle N, Paris A-S, Brun D, Dore G, Njamkepo E, Guillot S, Guiso N. 2012. Evolution of French bordetella pertussis and bordetella parapertussis isolates: increase of bordetellae not expressing pertactin. Clin. Microbiol. Infect. 18:E340 -346.
23. Octavia S, Sintchenko V, Gillbert GL, Lawrence A, Keil AD, Hogg G, Lan R. 2012. Newly emerging clones of bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008- 2010. J. Infect. Dis. 205:1220 -1224.
24. Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N. 2009. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 27:6034-6041.
25. Otsuka N, Han HJ, Toyoizumi-Ajisaka H, Nakamura Y, Arakawa Y, Shibayama K, Kamachi K. 2012. Prevalence and genetic characterization of pertactin-deficient bordetella pertussis in Japan. PLoS One 7:e31985. doi:10.1371/journal.pone.0031985.
26. Stefanelli P, Fazio C, Fedele G, Spensieri F, Ausiello CM, Mastrantonio P. 2009. A natural pertactin deficient strain of bordetella pertussis shows improved entry in human monocyte-derived dendritic cells. New. Microbiol. 32:159 -166.
27. Caro V, Njamkepo E, Van Amersfoorth S, Mooi FR, Advani A, Hallander HO, He Q, Mertsola J, Riffelmann M, Vahrenholz C, von König CHW, Guiso N. 2005. Pulsed-field gel electrophoresis analysis of bordetella pertussis population in various European countries with different vaccine policies. Microbes Infect. 7:976 -982.
28. Hallander H, Advani A, Riffelmann M, von König CHW, Caro V, Guiso N, Mooi FR, Gzyl A, Kaltoft MS, Fry NK, Mertsola J, He Q. 2007. bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J. Clin. Microbiol. 45:3257- 3262.
29. Van Amersfoorth S, Schouls LS, van der Heide HGJ, Advani A, Hallander HO, Bondeson K, von König CHW, Riffelmann M, Vahrenholz C, Guiso N, Caro V, Njamkepo E, He Q, Mertsola J, Mooi FR. 2005. Analysis of bordetella pertussis populations in European countries with different vaccination policies. J. Clin. Microbiol. 43:2837-2843.
30. Mooi FR, Hallander H, Wirsing von König CH, Hoet B, Guiso N. 2000. Epidemiological typing of bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis. 19:174- 181.
31. Advani A, Donnelly D, Hallander H. 2004. Reference system for characterization of bordetella pertussis pulsed-field gel electrophoresis profiles. J. Clin. Microbiol. 42:2890 -2897.
32. Khattak MN, Matthews RC. 1993. Genetic relatedness of bordetella species as determined by macrorestriction digests resolved by pulsed-field gel electrophoresis. Int. J. Syst. Bacteriol. 43:659-664.
33. Kallonen T, He Q. 2009. bordetella pertussis strain variation and evolution postvaccination. Expert Rev. Vaccine 8:863- 875.
34. Mooi FR. 2010. bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect. Genet. Evol. 10:36-49.
35. Tsang RS, Lau AK, Sill ML, Halperin SA, Van Caeseele P, Jamieson F, Martin IE. 2004. Polymorphisms of the fimbria fim3 gene of bordetella pertussis strains isolated in Canada. J. Clin. Microbiol. 42:5364 -5367.
36. van Gent M, Bart MJ, van der Heide HGJ, Heuvelman KJ, Mooi FR. 2012. Small mutations in bordetella pertussis are associated with selective sweeps. PLoS One 7:e46407. doi:10.1371/journal.pone.0046407.
37. Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, Tatti KM. 2012. Population diversity among bordetella pertussis isolates, United States, 1935-2009. Emerg. Infect. Dis. 18:1248 -1255.
38. Mosiej E, Augustynowicz E, Zawadka M, Dabrowski W, Lutynśka A. 2011. Strain variation among bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use. J. Clin. Microbiol. 49:1452-1457.